Search Results

A powder-free surgeon's glove is a device made of synthetic elastomer that is intended to be worn by operating room personnel to protect a surgical wound from contamination. In addition, these gloves were tested for use with chemotherapy drugs in accordance with ASTM D6978 Standard Practice for Assessment of Medical Gloves to Permeation by Chemotherapy Drugs and ASTM D6355-07, Standard Test Method for Human Repeat Insult Patch Testing of Medical Gloves.

A powder-free surgeon's glove is a device made of synthetic elastomer that is intended to be worn by operating room personnel to protect a surgical wound from contamination.

This document is an FDA 510(k) clearance letter for two types of surgical gloves (Flexylon Surgical Powder Free Gloves, Green and White variants). The core of this clearance is demonstrating substantial equivalence to a predicate device, which primarily relies on performance testing against established ASTM standards for chemotherapy drug permeation and dermatitis potential, rather than the kind of AI/machine learning study typically associated with your questions.

Therefore, many of the requested categories (e.g., "Sample sized used for the test set and the data provenance," "Number of experts used to establish the ground truth," "Adjudication method," "MRMC comparative effectiveness study," "Training set sample size," "Ground truth for the training set") are not applicable to this type of device clearance and the information provided in the document.

However, I can extract the relevant acceptance criteria and reported device performance from the document.

1. Table of Acceptance Criteria and Reported Device Performance

The acceptance criteria for chemotherapy drug permeation are implicitly defined by the results obtained when tested against the ASTM D6978 standard. For a glove to be considered "tested for use with chemotherapy drugs," the breakthrough detection time for each drug needs to be reported. There isn't a single universal "acceptance criterion" beyond demonstrating the performance as per the standard. For many drugs, a breakthrough time of ">240 minutes" indicates good resistance. For certain drugs, the breakthrough time is low, and the FDA has added warnings.

For the "Low Dermatitis Potential Claim," the acceptance criterion would be that the glove meets the requirements of ASTM D6355-07, which is "Standard Test Method for Human Repeat Insult Patch Testing of Medical Gloves." The document states the gloves were tested according to this standard, implying they met its criteria for a low dermatitis potential claim.

Study Proving Device Meets Acceptance Criteria:

The studies proving the device meets the acceptance criteria are referenced as:

• ASTM D6978 Standard Practice for Assessment of Medical Gloves to Permeation by Chemotherapy Drugs
• ASTM D6355-07, Standard Test Method for Human Repeat Insult Patch Testing of Medical Gloves

These are standardized testing methods, not complex AI or clinical studies. The results of these tests are presented in the tables above.

Non-Applicable / Not Provided Information:

For the remaining points, the information is either not applicable to this type of device submission or not provided in the FDA clearance letter:

2. Sample sized used for the test set and the data provenance: Not explicitly stated in the document. ASTM standards typically specify sample sizes for testing. The data provenance would be laboratory testing results.
3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts: Not applicable. The "ground truth" for permeation is determined by scientific measurement according to the ASTM D6978 standard, and for dermatitis potential by the ASTM D6355-07 standard. This does not involve expert consensus in the way an AI model might.
4. Adjudication method for the test set: Not applicable. Standardized laboratory testing methods are employed.
5. If a multi reader multi case (MRMC) comparative effectiveness study was done: No, this is not relevant for glove testing. This is typically for diagnostic imaging devices.
6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done: No, this is not an AI/algorithm-based device.
7. The type of ground truth used: For chemotherapy permeation, the ground truth is the directly measured breakthrough time of the drug through the glove material. For dermatitis potential, the ground truth is determined by the results of human repeat insult patch testing as per ASTM D6355-07.
8. The sample size for the training set: Not applicable, as this is not an AI/machine learning device.
9. How the ground truth for the training set was established: Not applicable, as this is not an AI/machine learning device.

Ask a specific question about this device